Barry Storer, PhD
Professor Emeritus
Clinical Research Division, Fred Hutch
Professor Emeritus
Public Health Sciences Division, Fred Hutch
Dr. Barry Storer is a statistician who helps optimize clinical trials. He collaborates with clinicians to identify the proper doses of new drugs and therapies that are both safe and effective.
Education
PhD, Biostatistics, University of Washington, 1984
MA, Zoology, University of Montana, 1977
BA, Zoology, University of New Hampshire, 1973
Research Interests
Dr. Storer works to optimally design clinical trials, including Phase III (randomized controlled trials of efficacy), Phase II (uncontrolled trials of efficacy, often with surrogate endpoints) and Phase I (dose-finding trials evaluating toxicity), especially using non-standard designs that might be advantageous with particular trial objectives. He has also focused on developing statistical methods that can identify patient, disease and treatment variables that significantly impact disease incidence and severity and/or outcomes with particular therapies.